ArticlePLOS global public health2025
Iron deficiency prevalence among pregnant women in Cambodia varies widely by trimester, inflammation adjustments, and across different ferritin thresholds.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Assessing the Discriminatory Ability of Hemoglobin Concentration to Predict Iron Stores in Cambodian Females: A Systematic Review and Individual Participant Data Meta-Analysis.Advances in nutrition (Bethesda, Md.) · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iron deficiency (ID) prevalence has been consistently reported as low among non-pregnant women in Cambodia, but less is known about iron status during pregnancy. Assessing iron status during pregnancy is critical, as deficiency can increase the risk of adverse pregnancy outcomes. We assessed anemia, ID, and inflammation prevalence in a cohort of pregnant women in Cambodia. Venous blood from 90 pregnant women (12-32 weeks' gestation) was collected before the start of a 2016 trial conducted in Prey Veng province. Gestational age was recorded on the same day as blood collection. Hemoglobin was measured on a hematology autoanalyzer, and ferritin, α-1 acid glycoprotein (AGP), and C-reactive protein (CRP) concentrations were measured with a sandwich-ELISA. Ferritin concentrations are presented as unadjusted and inflammation-adjusted (based on AGP and CRP concentrations). ANOVA and post-hoc pairwise t-tests were used to compare variables across trimesters of pregnancy. Mean±SD age of women was 26 ± 5 years. Most women (94%) reported consumption of iron and folic acid (IFA) tablets during pregnancy (mean±SD: 85 ± 19 tablets), and 72% received deworming treatment. Overall, 49% of women had anemia (hemoglobin <110 g/L for first and third trimesters; < 105 g/L for second trimester); with 43%, 34%, and 64% in the first, second and third trimester, respectively. ID prevalence (unadjusted ferritin <30 µg/L) ranged widely by trimester: 0%, 17% and 76% in the first, second and third trimester, as well as with use of a lower ferritin threshold (0-52%; < 15 µg/L), and whether ferritin was inflammation-adjusted (61% with and 43% without adjustment; < 30 µg/L). ID prevalence was high among women in third trimester, despite high IFA compliance. These findings underscore the need to consider the trimester of pregnancy in anemia and ID assessment. More research is needed to determine if trimester-specific thresholds for ferritin in pregnant populations are warranted and whether ferritin should be adjusted for inflammation in pregnancy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.